FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000508004: Great Britain English language reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001112010 Great Britain English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001113017 GB English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001114011 Great Britain English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


1327206 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
GB English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some

Members acceptabilityId
1,4-butanediol diacrylate only product Preferred (foundation metadata concept)
1,4-butanediol diacrylate-containing product Preferred (foundation metadata concept)
1,4-butanediol diglycidyl ether Preferred (foundation metadata concept)
1,4-butanediol diglycidyl ether (substance) Preferred (foundation metadata concept)
1,4-butanediol dimethacrylate Preferred (foundation metadata concept)
1,4-butanediol dimethacrylate (substance) Preferred (foundation metadata concept)
1,4-dicarboxybenzoate 1,2-dioxygenase Acceptable (foundation metadata concept)
1,4-diethylene dioxide Acceptable (foundation metadata concept)
1,4-dimethylbenzene Preferred (foundation metadata concept)
1,4-dimethylbenzene (substance) Preferred (foundation metadata concept)
1,4-dioxan Acceptable (foundation metadata concept)
1,4-lactonase Preferred (foundation metadata concept)
1,4-lactonase (substance) Preferred (foundation metadata concept)
1,4-phenylenediamine base Acceptable (foundation metadata concept)
1,4-phenylenediamine dihydrochloride Preferred (foundation metadata concept)
1,4-phenylenediamine dihydrochloride (substance) Preferred (foundation metadata concept)
1,5-anhydroglucitol Acceptable (foundation metadata concept)
1,5-anhydrosorbitol Preferred (foundation metadata concept)
1,5-anhydrosorbitol (substance) Preferred (foundation metadata concept)
1,6-alpha-L-fucosidase Preferred (foundation metadata concept)
1,6-alpha-L-fucosidase (substance) Preferred (foundation metadata concept)
1,6-bis(2,3-epoxypropoxy)hexane Acceptable (foundation metadata concept)
1,6-dihydroxycyclohexa-2,4-diene-1-carboxylate dehydrogenase Preferred (foundation metadata concept)
1,6-dihydroxycyclohexa-2,4-diene-1-carboxylate dehydrogenase (substance) Preferred (foundation metadata concept)
1,6-hexamethylene di-isocyanate Preferred (foundation metadata concept)
1,6-hexamethylene di-isocyanate (substance) Preferred (foundation metadata concept)
1,6-hexamethylene di-isocyanate only product Preferred (foundation metadata concept)
1,6-hexamethylene di-isocyanate-containing product Preferred (foundation metadata concept)
1,6-hexanediol diacrylate Preferred (foundation metadata concept)
1,6-hexanediol diacrylate (substance) Preferred (foundation metadata concept)
1,6-hexanediol diacrylate only product Preferred (foundation metadata concept)
1,6-hexanediol diacrylate-containing product Preferred (foundation metadata concept)
1,6-hexanediol diglycidyl ether Preferred (foundation metadata concept)
1,6-hexanediol diglycidyl ether (substance) Preferred (foundation metadata concept)
1-(1-(2-thienyl) cyclohexyl) piperidine Preferred (foundation metadata concept)
1-(1-(2-thienyl) cyclohexyl) piperidine (substance) Preferred (foundation metadata concept)
1-(1-methylpropoxycarbonyl)-2-(2-hydroxyethyl)piperidine Acceptable (foundation metadata concept)
1-(3-chlorophenyl)piperazine Acceptable (foundation metadata concept)
1-(4-isopropylphenyl)-3-phenyl-1,3-propanedione Preferred (foundation metadata concept)
1-(4-isopropylphenyl)-3-phenyl-1,3-propanedione (substance) Preferred (foundation metadata concept)
1-(4-nitrophenyl)-3-(3-pyridylmethyl)urea Acceptable (foundation metadata concept)
1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino]imidazole-4-carboxamide isomerase Preferred (foundation metadata concept)
1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino]imidazole-4-carboxamide isomerase (substance) Preferred (foundation metadata concept)
1-(dihydrogen phosphate)-1,2,3-propanetriol sodium salt Acceptable (foundation metadata concept)
1-1-bis-(p-chlorophenyl)-2-Nitrobutane Preferred (foundation metadata concept)
1-1-bis-(p-chlorophenyl)-2-Nitrobutane (substance) Preferred (foundation metadata concept)
1-1-bis-(p-chlorophenyl)-2-Nitropropane Preferred (foundation metadata concept)
1-1-bis-(p-chlorophenyl)-2-Nitropropane (substance) Preferred (foundation metadata concept)
1-1-dichloro-1-nitroethane Preferred (foundation metadata concept)
1-1-dichloro-1-nitroethane (substance) Preferred (foundation metadata concept)
1-2x/day Acceptable (foundation metadata concept)
1-3x/day Acceptable (foundation metadata concept)
1-4 weeks after intraocular haemorrhage degenerated red blood cells obstruct the trabecular meshwork causing ocular hypertension. Preferred (foundation metadata concept)
1-4x/day Acceptable (foundation metadata concept)
1-Butene Preferred (foundation metadata concept)
1-Butene (substance) Preferred (foundation metadata concept)
1-H-4-oxoquinoline 3-monooxygenase Acceptable (foundation metadata concept)
1-Methyl-4-(1-methylethenyl)cyclohexene Preferred (foundation metadata concept)
1-Methyl-4-(1-methylethenyl)cyclohexene (substance) Preferred (foundation metadata concept)
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism Acceptable (foundation metadata concept)
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism Acceptable (foundation metadata concept)
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism (disorder) Preferred (foundation metadata concept)
1-Methylhistidine Preferred (foundation metadata concept)
1-Methylhistidine (substance) Preferred (foundation metadata concept)
1-Methylhistidine measurement Preferred (foundation metadata concept)
1-Methylhistidine measurement (procedure) Preferred (foundation metadata concept)
1-Monoacylglycerol Preferred (foundation metadata concept)
1-Monoacylglycerol (substance) Preferred (foundation metadata concept)
1-N-ethyl sisomicin Acceptable (foundation metadata concept)
1-Naphthalene measurement Preferred (foundation metadata concept)
1-Naphthalene measurement (procedure) Preferred (foundation metadata concept)
1-Naphthol measurement Preferred (foundation metadata concept)
1-Naphthol measurement (procedure) Preferred (foundation metadata concept)
1-Pentanol measurement Preferred (foundation metadata concept)
1-Pentanol measurement (procedure) Preferred (foundation metadata concept)
1-Propanol Acceptable (foundation metadata concept)
1-Propyne Acceptable (foundation metadata concept)
1-STROKE ENVIRON Preferred (foundation metadata concept)
1-STROKE ENVIRON (product) Preferred (foundation metadata concept)
1-acylglycerol-3-phosphate acyltransferase Preferred (foundation metadata concept)
1-acylglycerol-3-phosphate acyltransferase (substance) Preferred (foundation metadata concept)
1-acylglycerophosphocholine acyltransferase Preferred (foundation metadata concept)
1-acylglycerophosphocholine acyltransferase (substance) Preferred (foundation metadata concept)
1-alkenyl-2-acylglycerol cholinephosphotransferase Preferred (foundation metadata concept)
1-alkenyl-2-acylglycerol cholinephosphotransferase (substance) Preferred (foundation metadata concept)
1-alkenylglycerophosphocholine O-acyltransferase Preferred (foundation metadata concept)
1-alkenylglycerophosphocholine O-acyltransferase (substance) Preferred (foundation metadata concept)
1-alkenylglycerophosphoethanolamine O-acyltransferase Preferred (foundation metadata concept)
1-alkenylglycerophosphoethanolamine O-acyltransferase (substance) Preferred (foundation metadata concept)
1-alkyl-2-acetylglycerol O-acyltransferase Preferred (foundation metadata concept)
1-alkyl-2-acetylglycerol O-acyltransferase (substance) Preferred (foundation metadata concept)
1-alkyl-2-acetylglycerol cholinephospho-transferase Preferred (foundation metadata concept)
1-alkyl-2-acetylglycerol cholinephospho-transferase (substance) Preferred (foundation metadata concept)
1-alkyl-2-acetylglycerophosphocholine esterase Preferred (foundation metadata concept)
1-alkyl-2-acetylglycerophosphocholine esterase (substance) Preferred (foundation metadata concept)
1-alkylglycerophosphocholine acetyltransferase Preferred (foundation metadata concept)
1-alkylglycerophosphocholine acetyltransferase (substance) Preferred (foundation metadata concept)
1-alkylglycerophosphocholine acyltransferase Preferred (foundation metadata concept)
1-alkylglycerophosphocholine acyltransferase (substance) Preferred (foundation metadata concept)
1-alpha, 25-Dihydroxy cholecalciferol Acceptable (foundation metadata concept)
1-alpha-hydroxylase deficiency Acceptable (foundation metadata concept)

Start Previous Page 58 of 13273 Next End


Reference Sets

Reference set descriptor

Back to Start